New publication – Attana’s technology employed to validate isolation of cholesterol carriers for application for patients having cardiovascular diseases
A new paper has been published in Scientific Reports by Prof. Riekkola and co-workers at the University of Helsinki and the group of Prof. Fornstedt at Karlstad University. In this paper, a new method to isolate cholesterol carrying particles from human plasma was developed. Attana's QCM technology was employed to evaluate the efficacy of the method.Low-density lipoproteins (LDL) is a main cholesterol carrier in the body and is considered the major risk factor for the development of atherosclerotic cardiovascular diseases. Rapid isolation of these LDL particles from human plasma is needed